<PAGE>
Scriptgen Pharmaceuticals, Inc.
200 Boston Avenue
Medford, Massachusetts 02155
February 27, 1998
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Filing Desk
Re: Scriptgen Pharmaceuticals, Inc.
Registration No. 333-40687
--------------------------
Gentlemen:
Scriptgen Pharmaceuticals, Inc. hereby withdraws the above-referenced
Registration Statement on Form S-1 under the Securities Act of 1933 due to
unattractive market conditions. Should you have any questions regarding the
foregoing, please feel free to call me at (781) 393-8001 or Steve Suzzan at
(212) 318-3092.
Very truly yours,
SCRIPTGEN PHARMACEUTICALS, INC.
By: /s/ Mark T. Weedon
-----------------------------
Mark T. Weedon
President and Chief Executive Officer